Skip to content

Original Research

Frontiers in Cancer Control and Society ·

Volume 4 - 2026 | https://doi.org/10.3389/fcacs.2026.1720333

Evaluation of the implementation of the national cancer registry of Senegal: lighting the way forward

  • Adama Sow1
  • Fatoumata Binetou Diongue1
  • Ibrahima Ndiaye1
  • Ndèye Marème Sougou1
  • Malick Anne2
  • Babacar Gueye3
  • Teddy Dramé2
  • Ndèye Mbombé Dieng2
  • Babacar Kane1
  • J. Andrew Dykens4,5,6
  • Caryn E. Peterson5,6,7
  • Adama Faye1*corresponding author
  1. 1Institute of Health and Development, Cheikh Anta Diop University, Dakar, Senegal
  2. 2Center for Disease Control, Division of Noncommunicable Diseases, Ministry of Health and Social Action, Dakar, Senegal
  3. 3Division of Planning, Research, and Statistics, Ministry of Health and Social Action, Dakar, Senegal
  4. 4Department of Family and Community Medicine, University of Illinois Chicago, Chicago, IL, United States
  5. 5Center for Global Health at the College of Medicine, University of Illinois Chicago, Chicago, IL, United States
  6. 6Cancer Center, University of Illinois Chicago, Chicago, IL, United States
  7. 7Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois Chicago, Chicago, IL, United States
Article metrics0 viewsView details

Abstract

Cancer is a real public health problem, the extent of which remains poorly understood due to the lack of reliable and up-to-date statistical data. Establishing a registry providing accurate data on prevalence and mortality is essential to improve the fight against cancer. Therefore, we felt it was appropriate to evaluate the implementation of the national cancer registry in Senegal and shed light on the next steps. A mixed-method study was conducted among Senegalese citizens aged 18–65, including ministry of health Officials, hospital managers, administrators, and clinicians. Quantitative data, collected through individual surveys (REDCap, face-to-face, or telephone) were analyzed using descriptive statistics. Qualitative data, from 18 semi-structured interviews, were transcribed, coded and analyzed using a hybrid thematic approach, supplemented by REA and Dedoose and QDA Miner software. This evaluation revealed that four (4/7; 57.14%) of the Ministry of Health Social Action (MoHSA) cancer registry team and eleven (11/20; 55.00%) hospital directors/clinical department heads endorsed the existence of clearly established standards for implementing the cancer registry in Senegal. Regarding the assertion that key stakeholders have collectively developed a workable plan to facilitate the implementation of a cancer registry in Senegal, all members of the MoHSA team and seven of them endorsed this assertion, compared to only seven (7/20; 35%) of the hospital directors/clinical department heads. Finally, all members (7/7; 100%) of the MoHSA registry team and 40% (8/20) 20) of hospital directors/heads of clinical departments agreed that the designated focal person is fully informed about the cancer registry. Indeed, the sustainability of the registry will also depend on the establishment of solid mechanisms for monitoring and controlling activities related to its management. All Ministry of Health officials agreed on the need for key stakeholders to collectively develop a feasible plan to facilitate the implementation of a cancer registry in Senegal. They recognize the registry's importance, but its partial implementation leads to data fragmentation, requiring resources and capacity building to ensure its sustainability.

Keywords

1 Introduction

Cancer, one of the major non-communicable diseases (NCDs), is undergoing a rapid epidemiological transition, particularly in sub-Saharan Africa, where cancer incidence is steadily increasing (1, 2). A comprehensive understanding of the cancer burden remains poorly understood due to a lack of reliable, timely data. According to GLOBOCAN 2022, 20 million new cases of cancer have been diagnosed worldwide, with almost 9.7 million deaths (3). The most frequently diagnosed cancers in terms of incidence were lung and breast cancer, representing 12.4% and 11.6% respectively, followed by colorectal cancer (9.6%), prostate cancer (7.3%) and stomach cancer (4.9%) (3).

In addition, over 35 million new cases of cancer are expected in 2050, an increase of 77% over the 20 million estimated in 2022, with the greatest increase in incidence expected in low-income countries (142% increase) (3).

In Africa, 1,185,216 cases of cancer were diagnosed in 2022 (4). Moreover, the cumulative risk of developing cancer before the age of 75 is 10.7% and 13.3% for men and women respectively (5).

Senegal is facing a market increase in cancers, with 11,814 new cases diagnosed in 2022 (6). In Senegal, cancer incidence and mortality are rising sharply, and cancer has become a significant public health problem. In 2022, 11,814 cases of cancer were diagnosed, with an estimated mortality rate of 81.6%. The five most frequent cancers during this period were cervical (2,065, 17.4%), breast (1,838, 15.5%), liver (1,144, 9.7%), prostate (913, 7.7%) and stomach (680, 5.7%). Prostate cancer is the most common type in men, while in women cervical cancer is most common (7).

Currently, Senegal lacks comprehensive data on the types of cancer, due to the absence of a functional registry, which was discontinued in 2015. Some data are available from independent cancer treatment centers, such as the Joliot Curie Institute (JCI), Dalal–Jam Hospital, and Cheikh Ahmadou Bamba Khadim Hospital which is the reference center for cancer care in Senegal. In 2020 at the IJC, a comprehensive cancer care facility and referral center for complex cases, 1,903 cases of cancer were diagnosed, with breast and cervical cancers predominating, making women the most affected group.

Senegal established a cancer registry in 2014 in eleven (11) public health facilities in the Dakar region, with plans to extend it to private clinics and regional hospitals. The specific objectives included adopting an online registration system, defining a work plan for tumor registration, and appointing official registrars for the 11 main institutions. Following this, registrations began and 2010 was set as the base year. However, problems were identified in most facilities, with the exception of four, including the Institute Curie, the main problems were data collection, difficult access to medical records archives, and the lack of an internet connection, which is essential for accessing the REGSEN system, as it is only available online. Incomplete information on tumors, as several cases were recorded based on the services registry, and the use of the REGSEN reserved exclusively for registrars. Despite these difficulties, some structures, such as the Grand Yoff General Hospital, had complete records from 2010 to 2014 due to their organization and the commitment of the various stakeholders.

Furthermore, analysis of the tumor registry in Senegal shows that, although operational, it remains hospital bases. Indeed, Senegal lacks a population bases cancer registry (8–10). In addition, the system also suffers from a lack of dedicated funding, making it difficult to sustain registration activities, staff training, and regular supervision (10).

Challenges are encountered in implementing cancer registries, as evidenced by the example in Nigeria, and how to overcome them through training, mentoring, scientific and logistical support, and awareness-raising, which are essential for maintaining cancer registration programs in low- and middle-income countries (LMICs) (7). Standardizing the registration process and improving data completeness are also important, as is political and financial support to maintain the registry (8).

The establishment of a national registry of cancer is essential to improve cancer control through the provision of accurate data on cancer incidence, prevalence, and mortality. This information is crucial for planning health services, allocating resources, and evaluating public health interventions (7, 11).

To date, studies thoroughly exploring the implementation of the registry in Senegal are very limited. This Knowledge gap hinders the clear identification of areas for improvement study involving multiple levels stakeholders. The objective of this research was to conduct an assessment of the implementation of the national cancer registry in Senegal in 2022, in order to inform the next steps.

This study analyzed the perspectives of stakeholders at multiple levels (national, organizational, implementer). Specifically, the aim was to evaluate the lessons learned from previous efforts in implementing the National Cancer Registry in Senegal in 2022; to analyse the organizational context, organizational readiness, and leadership capacity in relation in 2022; and to assess the structure, process, and capacity of Senegal's National Cancer Registry in 2022 in order to inform future program strengthening.

2 Methods

2.1 Study population

We conducted a case study using a mixed-methods (Quantitative + Qualitative) design. A cross-sectional survey of participants at several levels was conducted, followed by interviews with key informants. The study concerned one of the hospitals in Dakar (Aristide Le Dantec Hospital) and one of the regional hospitals (Thies Hospital). The population were included Ministry of Health (MOH) officials, Hospital administrators, heads of cancer clinical departments and hospital/registry office staff. Subjects were included in the study if they were: (1) Senegalese citizens aged 18–65; (2) willing to participate in survey assessments and individual interviews; data were collected using exhaustive sampling. Data were collected from four sampled of participants defined according to a non-probability sample. Within each of the four key information groups, intentionally selected for their specific roles. (A) Ministry of Health (MOH) officials (n = 6), (B) Hospital administrators (n = 6), (C) heads of cancer clinical departments (n = 10), or (D) hospital/registry office staff (n = 20). The total of target participant was 42.

For the qualitative approach, we used the purposive (intentional) sampling method. Qualitative interviews were carried out among a subset of participants. The sample targeted heterogeneity in age, ethnic origin, and gender, and was sufficient to achieve data saturation. Participants included: National Cancer Registry team at the Ministry of Health (n = 2), senior managers of the hospitals involved (n = 2), cancer department managers (n = 4) and registry staff/clinicians (4). A total of 18 interviews were conducted. Data for saturation was observed when the interviews for each professional category began to produce redundant information and no new information emerged.

2.2 Data collection

The interviewers were trained in the use of the data collection tools and the method of data collection, and the tools were pre-tested to ensure their effectiveness. Quantitative data collection took place through individual surveys of participants. Where participants had a computer and an internet connection, the survey was self-administered using REDcap software. For the others, face-to-face interviews were carried out, with the exception of one participant consulted by telephone due to his unavailability. Questionnaires were completed in private locations, with a member of the research team reading the questions in French. Responses were entered in duplicate (on a tablet and on paper), and anonymity was guaranteed. For this survey, specific questionnaires were developed for each of the four target groups: (A) Ministry of Health officials, (B) hospital executives, (C) hospital administrators, and (D) clinicians, staff or registrars. These collection tools were used to gather a variety of information, including demographic characteristics, leadership, organizational readiness and organizational context. Similarly, for the qualitative data, 18 semi-structured face-to-face interviews were conducted. Patients shared their views on various aspects such as usefulness, contextual relevance, credibility, sustainability, and integration of the program. The interviews took place in the participants' departments in Thies (5 days) and Dakar (14 days). Data were collected using pre-developed interview guides. Finally, the data collected were stored and shared electronically via a secure account on the Box online platform, in compliance with industry standards (Statement on Standards for Attestation Engagements–SSAE 16 and International Standard on Assurance Engagements (ISAE 3402)). Only approved members of the research team, in accordance with the protocol, have access to this data, guaranteeing its security and confidentiality.

2.3 Data analysis

Descriptive statistics were calculated at baseline on organizational context and readiness, as well as leadership capacity regarding the deployment, extension and sustainability of Senegal's National Cancer Registry. Characteristics of administrators and the study population were tabulated and stratified by stakeholder type to assess differences between these groups. Additionally, two research assistants collected and transcribed the data from the individual interviews. The data was coded by a socio-anthropologist researcher. A hybrid (deductive and inductive) thematic analysis approach was used, drawing on the theoretical framework of the normalization process (coherence, cognitive participation, collective action and reflexive monitoring). Rapid ethnographic assessment (REA) was used to explore the beliefs, attitudes and experiences of managers, administrators and staff, in order to adapt the registry program to the local context. Data were transcribed in encrypted form, and managed via Dedoose, following recommended strategies for data organization and analysis. The corpus of these transcribed interviews was used in the analysis and interpretation of the data. To make sense of the interviewees' various ideas, a thematic analysis was carried out. This consisted first of thoroughly rereading the textual data and coding it to generate themes. Similar themes and sub-themes were then grouped together. This exercise enabled us to obtain code books for the focus groups and individual interviews. Once the labeling process was complete, the synthesis of the report was facilitated by the narratives and examples from the interviews. Analysis was carried out using (Qualitative Data Analysis) QDA Miner software for improved management and interpretation.

Interview guide topics

  • Support from hospital staff for implementing CaReg in Senegal
  • Challenges faced by healthcare facilities in implementing CaReg
  • Impressions on the use of CaReg data
  • Recommendations on the use of data and its importance in decision-making

The project is guided by a research partnership comprising the Senegal Ministry of Health and Social Action (MoHSA), Cheikh Anta Diop University in Dakar (UCAD), and the University of Illinois Chicago (UI). This human subject research has been approved by the UIC Cancer Center Protocol Review Committee, the UIC Institutional Review Board, and the National Ethics Committee for Health Research at the Senegal MoHSA (SEN22/55). Research reported in this publication was supported by BIO Ventures for Global Health. This research was also supported in part by the Department of Family Medicine and the Center for Global Health at the University of Illinois at Chicago.

3 Results

3.1 Socio-demographic characteristics

A total of 41 individuals were surveyed, 18 of them women (Table 1). In addition, the respondents were distributed as follows: seven (7) MoHSA agents, 20 hospital administrators or department heads, and 14 clinicians or registrars. The respondents were distributed as follows (7 at MoHSA, 18 at the Thies regional hospital and 16 participants at the Aristide Le Dantec hospital, 48.8% (20/41) hospital administrators or department heads and 34.1% (14/41) personals clinicians or registrars.

Table 1. Distribution of informants by gender.

FeaturesSexTotal
Female *n* (%)Male *n* (%)
MSAS agent2 (28.6)5 (71.4)7
Hospital administrators/department heads7 (35.0)13 (65.0)20
Clinicians or registrars9 (64.3)5 (35.7)14
Total182341

This study revealed that the staff surveyed held the following positions: Director of the Research Planning and Statistics Directorate, Director of the Disease Control Directorate, Head of the Non-Communicable Disease Control Division, Cancer Registry Coordinator, Cancer Registry Manager, Head of the Cancer Office, Head of the IT Unit, Hospital Directors, Heads of Cancerology, Hematology Biology, Anatomy Pathology Laboratory, Oncology-Pediatrics, Gynecology, Nursing, Administrative and Financial, Principal Material Accountant, Doctors, Head of the Medical IT Unit, Head of the Chemotherapy Unit, Reception Manager, Chemotherapy Nurse Assistant, Focal Point, Management Controller, Nurse Registrar, IT Specialist, Data Manager, Medical Secretary, Ward Supervisor.

3.2 Leadership

Four members (4/7; 57.14%) of the MoHSA registry team and 11 (11/20; 55.00%) hospital administrators/clinical service leaders agreed on “The existence of clearly established standards for the implementation of the Cancer Registry in Senegal”. With regard to the statement that “key stakeholders have collectively developed a feasible plan to facilitate the implementation of a Cancer Registry in Senegal”, all MoHSA team members and seven (7/20; 35%) of hospital administrators/clinical service leadership agreed (Table 2).

Table 2. Key informants' opinions on the leadership of the national cancer registry in Senegal.

Leadership**Registry team at MSAS n = 7 (%)****Hospital administrators/Clinical services leadership n = 20 (%)**
Existence of clearly established standards for the implementation of the Cancer Registry in Senegal
In agreement4 (57.14)11 (55)
Others3 (42.86)9 (45)
Collective development by key stakeholders of a feasible plan to facilitate the implementation of a Cancer Registry in Senegal
In agreement7 (100)7 (35)
Others0 (0)13 (65)
Existence of a currently accepted plan that addresses and removes all major obstacles to the implementation of a Cancer Registry in Senegal
In agreement7 (100)5 (25)
Others0 (0)15 (75)
Existence of a designated leader/resource person for the implementation of a Cancer Registry in Senegal
In agreement7 (100)10 (50)
Others0 (0)10 (50)
Perfect knowledge of the designated leader/resource person of the details of the implementation, management and maintenance of a Cancer Registry in Senegal
In agreement7 (100)8 (40)
Others0 (0)12 (60)
Designated leaders/resource persons are able to adequately answer questions on the implementation of a Cancer Registry in Senegal
In agreement7 (100)10 (50)
Others0 (0)10 (50)
Ministry of Health management able to fully support the efforts of other stakeholders to implement a Cancer Registry in Senegal
In agreement7 (100)11 (55)
Others0 (0)9 (45)
Management in designated health facilities able to fully support staff in the effort to implement a Cancer Registry in Senegal
In agreement6 (85.71)11 (55)
Others1 (14.29)9 (45)
Recognition and appreciation by management of all the efforts of stakeholders for the implementation of a Cancer Registry in Senegal
In agreement6 (85.71)9 (45)
Others1 (14.29)11 (55)
Ability of the management team to persevere through the challenges of implementing a Cancer Registry in Senegal
In agreement6 (85.71)10 (50)
Others1 (14.29)10 (50)
Stakeholders at designated health facilities able to respond to challenges in a timely manner
In agreement6 (85.71)10 (50)
Others1 (14.29)10 (50)
Existence of an adequate and clear process for stakeholders to collectively respond to challenges in a timely manner as they arise
In agreement5 (71.43)6 (30)
Others2 (28.57)12 (70)

Regarding the statement “The currently accepted plan addresses and removes all major obstacles to the implementation of the Cancer Registry in Senegal”, all MSAS members (7/7; 100%) and five (5/20; 25%) hospital administrators/clinical services leadership agreed. In addition, all MoHSA registry team members (7/7; 100%) and half (10/20; 50%) of the hospital administrators/clinical services leadership agreed with the following statements: “There is clearly a designated leader/contact person for the implementation of a Cancer Registry in Senegal” and “The designated leader/contact person is able to adequately answer questions about the implementation of a Cancer Registry in Senegal” (Table 2).

All members (7/7; 100%) of the MoHSA registry team and 40% (i.e., 8/20) of hospital administrators/clinical department leaders agreed with the statement “The designated leader/contact person is fully aware of the details of implementing, managing and maintaining a Cancer Registry in Senegal”. Moreover, according to one interviewed: “In each department, I think we should perhaps designate a person in charge or a focal point in relation to this registry, and try to involve everyone in the process. The focal point is the one who will be responsible for boosting the use of this register” (Table 2).

However, only 30% (n = 7) of hospital and clinical administrators agreed on the following statement: “the existence of an adequate and clear process enabling stakeholders to collectively respond to challenges in a timely manner as they arise” (Table 2).

3.3 Organizational preparations for implementation of the national cancer registry

On the subject of prioritization, the results of the research revealed that 64.29% (i.e., 9/14) of clinicians and 50% (i.e., 10/20) of hospital administrators agreed with the statement that “a full commitment from hospital administrators is necessary in the implementation of a Cancer Registry in Senegal”. What's more, in the words of one department head interviewed, “All the conditions were in place, thanks to the availability of a high-performance information system, RegSen [Registre of Senegal], which enabled data to be recorded directly and reliably” (Table 3).

Table 3. Key informants' opinions on organizational preparation for the implementation of the national cancer registry in Senegal.

Assessment items**MSAS manager n = 7 (%)****Hospital administrators/Clinical services leadership n = 20 (%)****Clinicians-Registrars n =14 (%)**
Prioritization
Full commitment of hospital administrators in the implementation of a Cancer Registry in Senegal
In agreement4 (57.14)10 (50)9 (64.29)
Others3 (42.86)10 (50)5 (35.71)
Motivation of hospital administrators to implement a Cancer Registry in Senegal
In agreement4 (57.14)10 (50)5 (35.71)
Others3 (42.86)10 (50)9 (64.29)
Hospital administrators fully able to communicate the benefits of implementing a Cancer Registry in Senegal to their staff
In agreement1 (14.29)6 (30)7 (50)
Others6 (85.71)14 (70)7 (50)
Monitoring
Management of the policy for implementing this change by hospital administrators
In agreement7 (100)11 (55)12 (85.71)
Others0 (0)9 (45)2 (14.29)
Hospital administrators helping staff adapt to this change
In agreement7 (100)15 (75)5 (35.71)
Others0 (0)5 (25)9 (64.29)
Management
Monitoring the progress of implementing this change by hospital administrators
In agreement7 (100)13 (65)11 (78.57)
Others0 (0)7 (35)3 (21.43)
Management of challenges that may arise when implementing this change, by hospital administrators
In agreement7 (100)13 (65)10 (71.43)
Others0 (0)7 (35)4 (28.57)
Resources
Availability of financial resources among hospital administrators necessary for the implementation of a Cancer Registry in Senegal
In agreement1 (14.29)6 (30)3 (21.43)
Others6 (85.71)14 (70)11 (78.57)
Availability of human capacity among hospital administrators necessary for the implementation of a Cancer Registry in Senegal
In agreement5 (71.43)9 (45)6 (42.86)
Others2 (28.57)11 (55)8 (57.14)
Availability of equipment and materials necessary for the implementation of a Cancer Registry in Senegal among hospital administrators
In agreement5 (71.43)8 (40)4 (28.57)
Others2 (28.57)12 (60)10 (71.43)

In addition, 50% (n = 10) of hospital administrators/clinical department heads felt that “motivating hospital administrators to implement a Cancer Registry in Senegal” should be a priority. Moreover, 30% (i.e., 6/20) of hospital administrators felt they were fully able to communicate the benefits of implementing the Cancer Registry to their staff (Table 3).

In terms of resources, there was a range of agreement among clinician registrars that hospital administrators had the human capacity (6/14, 42.86%), financial resources (3/14, 21.43%), materials and equipment (4/14, 28.57) needed to implement the national cancer registry in Senegal. At the same time, over 30% (i.e., 6/20) of hospital administrators/clinical department leaders agreed that “hospital administrators have the human capacity, financial resources, materials and equipment needed to implement a cancer registry in Senegal” (Table 3).

3.4 Organizational context for the implementation of the National Cancer Registry

When it came to the recognition of evidence-based practices, around a third of hospital administrators and clinician registrars agreed that “hospital staff who work with the Cancer Registry are held in high esteem”. Furthermore, with regard to selection for evidence-based practices, 25.00% (i.e., 5/20) of hospital administrators and 57.14% (i.e., 8/14) of clinician registrars agreed that “Previous experience of hospital staff in tasks associated with the maintenance of a Cancer Registry”. Similarly, 20% (i.e., 4/20) of hospital administrators agreed that “Training of hospital staff on the Cancer Registry”. Indeed, according to some researchers interviewed: “Once these registers have been set up, training is needed to make them sustainable, and to exploit the data so that long-term policies can be put in place to curb this phenomenon” (Table 4).

Table 4. Opinions of key informants regarding the organizational context of the implementation of the national cancer registry in Senegal.

Keys items/ questions evaluated**Hospital administrators n = 20 (%)****Clinicians-Registrars n = 14 (%)**
Recognition for evidence-based practices (EBP)
Hospital staff who work with the Cancer Registry, considered clinical experts
In agreement8 (40)2 (14.29)
Others12 (60)12 (85.71)
Hospital staff working with the Cancer Registry, held in high esteem
In agreement7 (35)5 (35.71)
Others13 (65)9 (64.29)
Selection for evidence-based practices (EBP)
Previous experience of hospital staff in tasks associated with the maintenance of a Cancer Registry
In agreement5 (25)8 (57.14)
Others15 (75)6 (42.86)
Training of hospital staff on the Cancer Registry
In agreement4 (20)5 (35.71)
Others16 (80)9 (64.29)
Focus on evidence-based practices (EBP)
Hospital staff's opinion on the importance of implementing a Cancer Registry
In agreement15 (75)12 (85.71)
Others5 (25)2 (14.29)
Hospital staff's opinion on the management of a Cancer Registry which is an absolute priority
In agreement16 (80)10 (71.43)
Others4 (20)4 (28.57)
Educational support for evidence-based practices (EBP)
Existence of adequate training for administrators for the prior implementation of the Cancer Registry in Senegal
In agreement6 (30)6 (42.86)
Others14 (70)8 (57.14)
Existence of adequate staff training, for the prior implementation of the Cancer Registry in Senegal
In agreement6 (30)4 (28.57)
Others14 (70)10 (71.43)
Establishment of an adequate training plan for implementation staff to ensure that they manage all tasks of a Cancer Registry in a comprehensive and timely manner.
In agreement7 (35)4 (28.57)
Others13 (65)10 (71.43)
Existence of adequate training materials to support the daily work of a Cancer Registry
In agreement7 (35)5 (35.71)
Others13 (65)9 (64.29)
Existence of a plan of periodic workshops and seminars to ensure that all administrators and staff are fully aware of all the requirements for running a successful Cancer Registry, including updates, improvements and success reporting.
In agreement4 (20)5 (35.71)
Others16 (80)9 (64.29)

With regard to educational support, 35% (i.e., 7/20) of hospital administrators fully agreed with: “there is an adequate training plan in place for implementers to ensure that they manage all the tasks of a Cancer Registry in a comprehensive and timely manner”, as well as “there are adequate training materials to support the day-to-day work of a Cancer Registry”. Similarly, 35.71% (i.e., 5/14) of clinician registrars fully agreed with the statement that “there is a plan for periodic workshops and seminars to ensure that all administrators and staff are fully aware of all the requirements for running a successful Cancer Registry, including updates, improvements and success reports” (Table 4).

4 Discussion

The evaluation of the implementation of the national cancer registry in Senegal was carried out with 41 participants, divided between agents from the MoHSA (7), hospital administrators/heads of department (20) and clinicians/registrars (14).

The interpretation of the results highlights structural organizational, and human challenges that go beyond a simple description of the data collected. These difficulties lack of sustainable funding, insufficient training, fragmented governance, and inadequate technological tools are not unique to Senegal but are part of a pattern widely documented in Sub-Saharan African countries (12).

The results show that only 25% of hospital administrators, com 75.14% of clinician registrars agreed on the inclusion of previous hospital staff experience in the tasks associated with maintaining a Cancer Registry. This demonstrates a partial consensus on the value of prior experience in the implementation strategy. However, the literature clearly emphasizes that field expertise and adequate staff training are essential to ensure the quality, completeness, and reliability of cancer registry data (5, 12).

This research revealed that only 21% to over 40% of clinician registrars and hospital administrators agreed that hospital administrators had the financial resources, materials and equipment necessary to implement a national cancer registry in Senegal. Indeed, despite the importance of local cancer data, many existing registries did not have the technical (13) or financial (14) resources to collect complete data in Senegal. Cost estimates from a recent study on cervical cancer screening and treatment in Senegal highlight the financial implications of cancer control activities within the health system (22). Financial constraints were the main challenge observed during the implementation of the cancer registry. According to a member of the NCDs Division team, the cessation of WHO financial support led to a drop in registrar motivation, compromising the continuation of activities. Some of them also point to other causes, notably the lack of monitoring and evaluation, as well as a lack of organization. Similarly, the experience in Nigeria shows that even with an organized system, the sustainability of the registry depends on dedicated national funding, partner support, and stable institutional mechanisms (15). Furthermore, in Uganda, activity-based analysis by Maciosek et al. revealed high costs related to trained staff, travel to collect data, and the need for specialized software (16).

Furthermore, although training sessions had been set up, only 30% of hospital administrators and 28.57% of clinician registrars agreed on the existence of adequate staff training for the implementation of the cancer registry in Senegal. Moreover, a management controller at Le Dantec Hospital emphasized the need to expand staff training. These findings are consistent with those of Brenda Mallon and al. who also identified a need for staff training for the implementation of a childhood cancer registry in Dakar (8). Izquierdo et al. (13) also stressed the need for adequate staff training when setting up cancer registries. Indeed, thorough and regular training of staff is essential to guarantee the quality and durability of the data collected (17). Indeed, within the cycle of a learning healthcare system, high-quality data is a fundamental lever for producing actionable knowledge (Data to Knowledge). In addition, these data are used by health planners, researchers, policy-makers and the public to guide prevention efforts and monitor cancer trends (4).

All MoHSA officials indicated that the implementation and supporting staff should be managed by hospital administrators. This underlines the key role played by hospital administrators in the leadership, oversight and management of the registry. Indeed, as the manuscript “Cancer registration: Principles and Methods” from the World Health Organization and the International Agency for Research on Cancer points out, the success of a cancer registry depends not only on high-quality data, but also on support for the staff involved in data collection (18). Indeed, according to the results of individual interviews with facility managers, the implementation of the cancer registry has mobilized strong commitment from key players, notably hospital doctors and professors, the Ministry of Health as the lead entity, and the technical partners involved in the process.

Furthermore, this study shows that stakeholder efforts were recognized and appreciated by 85.71% of Ministry of Health members and 45% of hospital administrators/clinical service leaders. These results are comparable to those of Petkovic et al. (19), who argue that stakeholder engagement is a key factor in the development and implementation of guidelines. It is therefore essential that all stakeholders, including the country's political decision-makers, local authorities, community partners, key opinion leaders and local experts, are involved, as this guarantees the success and sustainability of the project (18, 20).

In addition, all Ministry of Health officials agreed on the need for the collective development by key stakeholders of a workable plan to facilitate the implementation of a Cancer Registry in Senegal. These results underline the importance of proactive leadership in management as a key factor in the success of the project (18). Indeed, research on cancer registration in sub-Saharan Africa showed that a lack of coordination and leadership, tainted by mismanagement and corruption, constituted a major challenge to collection (12).

With regard to selection for evidence-based practices, this research revealed that 75.14% of clinician registrars agreed on the need to include the previous experience of hospital staff in the tasks associated with maintaining a Cancer Registry. This observation is in line with the findings of Pisansky et al. (20), who emphasize that the most effective strategies and approaches are those derived from evidence-based processes, including all studies and results deemed relevant. This ensures optimal implementation of healthcare interventions. However, it is worrying to note that only 20% of hospital administrators surveyed fully endorse the statement that “there is a plan for periodic workshops and seminars to ensure that all administrators and staff are fully aware of all the requirements to run a successful Cancer Registry, including updates, improvements and success reports”. This falls well short of the requirements of the National Cancer Registry Program (NPCR), which insists on adherence to registry standards such as quality, completeness and timeliness in data collection (21).

5 Limitations

This study is essentially limited to a descriptive analysis, without recourse to in-depth statistical tests. The results presented are therefore based on findings supported by qualitative analysis, and do not allow statistical relationships between variables to be established. This calls for further investigation in future research. The relatively small sample size limits statistical power and restricts the scope of the conclusions. Furthermore, the self-reported nature of the data exposes the study to potential social desirability bias, leading to a tendency to conform to perceived expectations. Additionally, in 2014, most of the facilities visited faced challenges in data collection and medical record archiving, except for a few institutions such as the Curie Institute and the Grand Yoff General Hospital. For example, Youssou Mbargane Diop Hospital in Rufisque had no internet access, which made it impossible to use the online registry on-site, forcing the registrar to work from home. Finally, the generalizability of the results remains limited, as the observations cannot be extrapolated to the entire population. It should be noted that this study coincided with the relocation of Le Dantec Hospital, which led to the transfer of certain services to Guediawaye Hospital. This situation was not conducive to meetings between the various stakeholders.

6 Conclusion

This study revealed that the actors involved in the implementation of the cancer registry are aware of its importance for the development of public health policies and the implementation of preventive actions. This scaling up would contribute to having a broader vision of what is happening on the ground. However, the implementation of the registry in only certain structures leads to fragmented data. Thus, it would be necessary to capitalize on the data of private structures in order to have complete information and to pool efforts. However, to achieve these objectives, it is imperative to mobilize human, financial and material resources necessary for the implementation and sustainability of the registry. It is also crucial to ensure the capacity building of hospital administrators and registrars, to designate focal points as well as motivated registrars, in order to guarantee adequate surveillance and management of cancer data. Indeed, the sustainability of the registry will also depend on the establishment of solid mechanisms for tracking and monitoring activities related to its management.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcacs.2026.1720333/full#supplementary-material

Supplementary material Supplementary material at the source

Supplementary material Supplementary material at the source

Supplementary material Supplementary material at the source

Supplementary material Supplementary material at the source

Supplementary material Supplementary material at the source

Supplementary material Supplementary material at the source

Supplementary material Supplementary material at the source

Footnotes

Edited by: Petar Ozretić, Rudjer Boskovic Institute, Croatia

Reviewed by: Yuhang Wang, South China University of Technology, China

Shubharanjan Jena, Regional Medical Research Center (ICMR), India

Footnotes

CDC, Centers for Disease Control and Prevention; NCDs, non communicable diseases; IJC, Joliot Curie Institute; MoHSA, Ministry of Health and Social Action; WHO, World Health Organization.

Statements

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.

Funding

The author(s) declared that financial support was received for this work and/or its publication. Research reported in this publication was supported by BIO Ventures for Global Health. This research was also supported in part by the Department of Family Medicine and the Center for Global Health at the University of Illinois at Chicago.

Data availability

The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding author.

Ethics approval

The studies involving humans were approved by Comité national d'éthique et de recherche en Santé (CNERS) du Ministère de la Santé et de l'action sociale (MSAS) Sénégal: protocole SEN22/55. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

AS: Writing – review & editing, Supervision, Writing – original draft, Visualization. FD: Software, Data curation, Visualization, Conceptualization, Writing – original draft, Methodology, Writing – review & editing, Validation, Supervision, Formal analysis, Investigation. IN: Visualization, Validation, Writing – review & editing, Formal analysis. NS: Validation, Conceptualization, Investigation, Writing – review & editing. MA: Funding acquisition, Validation, Visualization, Writing – review & editing, Conceptualization. BG: Visualization, Validation, Writing – review & editing, Conceptualization. TD: Investigation, Writing – review & editing, Methodology, Visualization, Formal analysis. ND: Visualization, Validation, Investigation, Writing – review & editing. BK: Visualization, Methodology, Formal analysis, Software, Writing – review & editing, Investigation. JD: Funding acquisition, Resources, Writing – review & editing, Writing – original draft, Visualization, Methodology, Validation, Project administration, Conceptualization, Supervision. CP: Methodology, Writing – review & editing, Conceptualization, Visualization, Validation. AF: Writing – review & editing, Funding acquisition, Methodology, Supervision, Investigation, Writing – original draft, Data curation, Resources, Validation, Conceptualization, Project administration, Visualization.

Acknowledgements

The authors would like to acknowledge and thank all members of the National Advisory Board including Mamadou Moustapha Diop MD [the Director of Disease Control at the Senegal Ministry of Health and Social Action (MSAS)], Malick Hanne MD (Non-Communicable Disease Division Head at MSAS) as well as the whole division team, the World Health Organization regional representatives, the Senegalese League Against Cancer (LISCA), and Ababacar Mbaye MD and Ndeye Magatte Ndome Ndiaye MD (the Kedougou and Dakar Regional Health Directors, respectively). We are also grateful to members of the Kedougou Regional Implementation Research Team including the following regional officials: Mamadou Diop MD (the Kedougou District Chief Medical Officer), Mama Saliou Sall MD (Kedougou Regional Social Action Director); Dembele Fatou Traore (the Kedougou Regional Reproductive Health Coordinator); and Dienabou Diallo, Seck Oulimata Sane, and Fatou Faye (the District-level Reproductive Health Coordinators of Kedougou, Saraya, and Salemata, respectively). We deeply appreciate the work of the health system personnel and implementation teams including nurses, midwives, and community health workers at the following health facilities: The Saraya Health Center, Bembou health post, and Diakha Macky health post in the Saraya District, the Salemata Health Center and Health Posts at Darou Ningou health and Dar-Salam in the Salemata District, and the Kedougou Health Center and the Health Posts at Dimboli and Fongolimby in the Kedougou District. We would like to thank members of the Dakar Regional Implementation Research Team including the following regional officials: Fatou Kasse MD (the Head of the Monitoring and Evaluation Office of the Dakar Regional Health Direction); Abdoulaye Ba MD, Gabriel Massene Senghor MD, Mbaye Diop MD (the Keur Massar, Yeumbeul and Diamniadio District Chief Medical Officers, respectively); and Thiaba Cisse, Marie Sylviana Sambou, and Safietou Bathe (District Reproductive Health Coordinators of Keur Massar, Yeumbeul, and Diamniadio Districts, respectively). With gratitude, we recognize the work of the health system personnel and implementation teams including nurses, midwives, and community health workers at the following health facilities: The Keur Massar Health Center, Mme Fatou Ba Health Post, and Boune Health Post in the Keur Massar District; the Yeumbeul Health Center and the Health Posts at Maternite Yeumbeul Nord and Yeumbeul Diamalaye in the Yeumbeul District; and the Diamniadio Health Center and the Health Posts at Niangal and Sebikotane in the Diamniadio District. We are also extraordinarily indebted to the local research assistants who ensured that all of the work was accomplished. Thanks, are also due to Professor Oumar Bassoum MD MPH PhD, Rey A Flores MA LSW, Abigail Suleman MPH, Melissa Vargas RN MPH PhDc, and Taylor Abbey PhD who contributed to the early development of this work. In addition, we are grateful for those who have provided support from the University of Illinois at Chicago for this project including Mas Jimbo MD, Memoona Hasnain MD MHPE PhD, Stevan Weine MD, among many others. We are also grateful to David Peters MD DrPH, Crystal L. Patil PhD, and Melissa Simon MD MPH for mentorship in the early development of this project.

References

  1. 1. Ayandipo O, Wone I, Kenu E, Fasehun L-K, Ayandipo O, Gaye F. Cancer ecosystem assessment in West Africa: health systems gaps to prevent and control cancers in three countries: Ghana, Nigeria and Senegal. Pan Afr Med J. (2020) 35: 90. doi: doi:10.11604/pamj.2020.35.90.18516
  2. 2. Ngwa W, Addai BW, Adewole I, Ainsworth V, Alaro J, Alatise OI. Cancer in sub-Saharan Africa: a lancet oncology commission. Lancet Oncol. (2022) 23: e251 – 312. doi: doi:10.1016/S1470-2045(21)00720-8
  3. 3. Union for international Cancer Control (UICC). GLOBOCAN 2022: Latest Global Cancer Data Shows Rising Incidence and Stark Inequities | UICC. Available online at: (Accessed December 11, 2025).
  4. 4. International Agency for Research on Cancer (IARC). Homepage – IARC. Available online at: (Accessed December 11, 2025).
  5. 5. International International Agency for Resarch on Cancer World Health Organization. GLOBOCAN 2022: Western Africa fact sheeet. Lyon: IARC (2022).
  6. 6. International Agency for Research on Cancer (IARC). 686-Senegal-fact-sheet.
  7. 7. Baldé S, Ba O, Diop M, Diouf GNT. Establishment of a cancer registry in Senegal: preliminary results. Afr J Oncol. (2021) 1: 15 – 6. doi: doi:10.54266/ajo.1.1.15.15
  8. 8. Mallon B, Dial C, Akonde FB, Ahouidi MJD, Diouf N, Anne M. The path towards a population-based childhood cancer registry in the region of Dakar in Senegal: a feasibility study of the Franco-African paediatric oncology group (GFAOP). EJC Paediatr Oncol. (2025) 6: 100420. doi: doi:10.1016/j.ejcped.2025.100420
  9. 9. Ayubi E, Lyus R, Brhlikova P, Pollock AM. A critical appraisal of the quality of data submitted by sub-Saharan African cancer registries to GLOBOCAN 2020. JRSM Open. (2024) 15: 20542704231217888. doi: doi:10.1177/20542704231217888
  10. 10. Bouri N-V, Ba O, Dieme J-L, Mbengue M, Boye A, Fall T. État des lieux du registre des tumeurs au Sénégal: bilan à 6 ans d'enregistrement en ligne. Rev Mal Respir. (2017) 34: A75. doi: doi:10.1016/j.rmr.2016.10.156
  11. 11. Tervonen HE, Bray F, Foliaki S, Roder D. Cancer registration challenges in low- and middle-income countries-the case of the Pacific Islands. Eur J Cancer Care. (2017) 26. doi: doi:10.1111/ecc.12650
  12. 12. Omonisi AE, Liu B, Parkin DM. Population-based cancer registration in Sub-Saharan Africa: its role in research and cancer control. JCO Glob Oncol. (2020) 6: 1721 – 8. doi: doi:10.1200/GO.20.00294
  13. 13. Izquierdo JN, Schoenbach VJ. The potential and limitations of data from population-based state cancer registries. Am J Public Health. (2000) 90: 695 – 8. doi: doi:10.2105/AJPH.90.5.695
  14. 14. Ellington TD, Henley SJ, Wilson RJ, Senkomago V, Wu M, Benard V. Cancer survival in the United States 2007–2016: results from the national program of cancer registries. PLoS One. (2023) 18: e0284051. doi: doi:10.1371/journal.pone.0284051
  15. 15. Jedy-Agba EE, Oga EA, Odutola M, Abdullahi YM, Papoola A, Achara P. Developing national cancer registration in developing countries – case study of the Nigerian national system of cancer registries. Front Public Health. (2015) 3: 186. doi: doi:10.3389/fpubh.2015.00186
  16. 16. Wabinga H, Sujha Subramanian, Nambooze S, Amulen PM, Edwards P, Joseph R. Uganda experience-using cost assessment of an established registry to project resources required to expand cancer registration. Cancer Epidemiol. (2016) 45: S30 – 6. doi: doi:10.1016/j.canep.2016.11.004
  17. 17. Palis BE, Janczewski LM, Browner AE, Cotler J, Nogueira L, Richardson LC. The national cancer database conforms to the standardized framework for registry and data quality. Ann Surg Oncol. (2024) 31: 5546 – 59. doi: doi:10.1245/s10434-024-15393-8
  18. 18. Jensen OM Parkin DM MacLennan R Muir CS Skeet RG World Health Organization. Cancer Registration: Principles and Methods. In: IARC Scientific Publications, No. 95, International Agency for Research on Cancer, Lyon, France. Oxford: Oxford University Press (1991).
  19. 19. Petkovic J, Riddle A, Akl EA, Khabsa J, Lytvyn L, Atwere P. Protocol for the development of guidance for stakeholder engagement in health and healthcare guideline development and implementation. Syst Rev. (2020) 9: 21. doi: doi:10.1186/s13643-020-1272-5
  20. 20. Pisansky TM, Thompson IM, Valicenti RK, D'Amico AV, Selvarajah S. Adjuvant and salvage radiotherapy after prostatectomy: ASTRO/AUA guideline amendment 2018–2019. J Urol. (2019) 202: 533 – 8. doi: doi:10.1097/JU.0000000000000295
  21. 21. Edwards P, Bernacet A, Tangka FKL, Pordell P, Beizer J, Wilson R. Operational characteristics of central cancer registries that support the generation of high-quality surveillance data. J Regist Manag. (2022) 49: 10 – 6.
  22. 22. Diop A, Mvundura M, Dieng Y, Anne M, Vodicka E. Cervical cancer screening and treatment costing in Senegal. Pan Afr Med J. (2024) 47: 151. doi: doi:10.11604/pamj.2024.47.151.41485

Citation

Sow, A., et al. (2026). Evaluation of the implementation of the national cancer registry of Senegal: lighting the way forward. Frontiers in Cancer Control and Society, Volume 4. https://doi.org/
Received
Accepted
Published
Volume
4 - 2026

Copyright

Copyright © 2026 Sow, Diongue, Ndiaye, Sougou, Anne, Gueye, Dramé, Dieng, Kane, Dykens, Peterson and Faye.

License: https://creativecommons.org/licenses/by/4.0/

*Correspondence: Adama Faye

Article metrics

Views
0
Downloads
0
Citations
0
Shares
0